We found no evidence to assess the benefits and harms of early versus delayed EPO for the anaemia of ESKD.

Recomendaciones para el uso racional de la prueba 25-hidroxivitamina D Resumen de políticaRecommendations for the rational use of the 25-hydroxyvitamin D test

Eficacia y seguridad de la cloroquina, la hidroxicloroquina y la azitromicina en pacientes con COVID-19 e2500-5006Revista Colombiana de Nefrología

Background The measurement of the experience perceived and reported by patients and families is essential to improve the care process. In the literature, a wide variety of questionnaires and supra-specialized scales are provided for services, pathologies or areas of care, making it difficult to compare their results. Our objective was to design and psychometrically validate a questionnaire to measure the experience of patients treated in hospitals and outpatient services and possibly virtual services.Method This was a survey and validation study of instruments with adult patients treated in eight clinics and 28 medical centers. The QEx-P Questionnaire was designed and administered electronically. Construct validity was evaluated with AFE and CFA; convergent and discriminant validity with Spearman's coefficient and Fornell's criterion, respectively; and reliability with Cronbach's alpha.Results A total of 2972 surveys were analyzed. In the validation of the construct, 12 models were estimated, finding a better goodness of fit in the 5-factor models for outpatient and hospital care and 1-factor for virtual care. The convergent validity showed a moderate correlation with the NPS. The discriminant validity was indeterminate. Reliability showed high internal consistency.Conclusion The questionnaire designed and validated in this study has psychometric validity and reliability as a tool to measure the experience reported by Spanish-speaking patients attended in outpatient and hospital services, in addition to being potentially useful for measurement in virtual services (calls or telehealth).

Recomendaciones para el uso de la hormona de crecimiento humana recombinante en pacientes pediátricos de talla baja en ColombiaRecommendations for treatment with recombinant human growth hormone in pediatric patients in Colombia